If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Euro. Regulatory News (JEGI)

Share Price Information for Jpmorgan Euro. (JEGI)

Share Price is delayed by 15 minutes
Get Live Data
146.80    -0.40 (-0.27%)
Bid:
146.60
Ask:
147.00
Spread: 0.40 (0.273%)
Market Cap: £620.03m
JEGI Live PriceLast checked at - London Stock Exchange

Intraday Jpmorgan Euro. Share Chart

New Research

Today 11:58

RNS Number : 7401L
JPMorgan European Grwth & Inc PLC
09 July 2026
 

London Stock Exchange Announcement

RNS Reach

JPMorgan European Growth & Income plc

(the 'Company' or 'JEGI')

 

Legal Entity Identifier: 549300D8SPJFHBDGXS57

 

JPMorgan European Growth & Income: New Research

Balanced Approach Providing Core Exposure

 

The Investment Trust Research team at Winterflood, a division of Marex Financial, has produced a 'Fund Insight' research report about JPMorgan European Growth & Income, providing an overview of the fund's strategy and performance to help investors better understand the investment approach, portfolio composition and outlook for this investment trust. This note is free to read for UK investors. Click here to read the report

 

Important information

Marex Financial ("MF") is authorised and regulated by the Financial Conduct Authority (FCA registration number 442767). The company covered in this report has appointed and paid MF to write this research. MF has structured its business to manage any conflicts of interest. Further details regarding conflicts, risks, and other investor educational information can be found in the Glossary & Disclaimer section of the report.

This report contains general information and does not constitute and shall not be implied to constitute an investment recommendation, a personal recommendation or advice, or an offer/solicitation to buy or sell or take any action in relation to any investments mentioned herein. MF cannot provide advice relating to legal, tax, financial matters and as such you should seek independent professional advice before making any investment decision. MF accepts no liability whatsoever in connection with any decision that you make in connection with this report. This report is based on information obtained from sources believed to be reliable, but which have not been independently verified and are not guaranteed as being accurate.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments.

This research report is not intended for distribution to, or use by, any individuals or entities based in the US or any jurisdictions where there are restrictions for such activity under local law or regulation which would subject MF to regulatory authorisations.

 

Stay Informed

The Company delivers email updates on its progress with regular news and views, as well as the latest performance. If you would like to receive these communications, you can register here.

 

9th July 2026

For further information, please contact:

Alexandra Ellaby

E-mail:  alexandra.ellaby@jpmorgan.com

Tel: 02077426100

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASSWFSUEMSEIW
Date   Source Headline
9th Jul 202611:58 amRNS-RNew Research
9th Jul 202610:31 amRNSNet Asset Value(s)
8th Jul 202610:31 amRNSNet Asset Value(s)
7th Jul 20263:09 pmRNS-RInitiation note from QuotedData
7th Jul 202610:29 amRNSNet Asset Value(s)
6th Jul 202610:57 amRNSGearing Announcement
6th Jul 202610:12 amRNSNet Asset Value(s)
3rd Jul 202610:56 amRNSNet Asset Value(s)
2nd Jul 202611:09 amRNSNet Asset Value(s)
2nd Jul 20267:00 amRNSPublication of Circular
1st Jul 20263:57 pmRNSDividend Declaration
1st Jul 202612:12 pmRNSNet Asset Value(s)
30th Jun 202611:25 amRNSNet Asset Value(s)
29th Jun 202611:57 amRNSGearing Announcement
29th Jun 202611:10 amRNSNet Asset Value(s)
26th Jun 202611:37 amRNSNet Asset Value(s)
25th Jun 202610:51 amRNSNet Asset Value(s)
25th Jun 20269:03 amRNS-RQuotedData's In The HotSeat Special
24th Jun 202611:01 amRNSNet Asset Value(s)
23rd Jun 202610:43 amRNSNet Asset Value(s)
23rd Jun 20267:00 amRNSFinal Results
22nd Jun 202611:00 amRNSGearing Announcement
22nd Jun 202610:30 amRNSNet Asset Value(s)
19th Jun 202611:03 amRNSNet Asset Value(s)
18th Jun 202610:26 amRNSNet Asset Value(s)
17th Jun 202611:11 amRNSNet Asset Value(s)
16th Jun 202611:03 amRNSNet Asset Value(s)
15th Jun 202611:19 amRNSGearing Announcement
15th Jun 202610:59 amRNSNet Asset Value(s)
12th Jun 202611:57 amRNSNet Asset Value(s)
12th Jun 202610:22 amRNSTen Largest Investments
11th Jun 202610:57 amRNSNet Asset Value(s)
11th Jun 20267:00 amRNS-RInvestor Webinar: 15th June 2026 3:00 pm BST
10th Jun 202611:53 amRNSNet Asset Value(s)
9th Jun 202610:46 amRNSNet Asset Value(s)
8th Jun 202610:58 amRNSGearing Announcement
8th Jun 202610:41 amRNSNet Asset Value(s)
5th Jun 202611:26 amRNSNet Asset Value(s)
4th Jun 202611:01 amRNSNet Asset Value(s)
3rd Jun 202610:58 amRNSNet Asset Value(s)
2nd Jun 202611:12 amRNSNet Asset Value(s)
1st Jun 202611:50 amRNSGearing Announcement
1st Jun 202611:18 amRNSNet Asset Value(s)
29th May 202610:40 amRNSNet Asset Value(s)
29th May 20267:00 amRNSProposed Rollover of Assets from EOT
28th May 202610:43 amRNSNet Asset Value(s)
27th May 202611:20 amRNSNet Asset Value(s)
26th May 20261:59 pmRNSGearing Announcement
26th May 202612:12 pmRNSNet Asset Value(s)
22nd May 202611:46 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.